“Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors” (2026) Canadian Hematology Today, 5(s02), pp. 2–7. doi:10.58931/cht.2026.5s0282.